Jingsheng Tuo

4.6k total citations
109 papers, 3.6k citations indexed

About

Jingsheng Tuo is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jingsheng Tuo has authored 109 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Ophthalmology, 56 papers in Molecular Biology and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jingsheng Tuo's work include Retinal Diseases and Treatments (60 papers), Retinal Development and Disorders (29 papers) and Glaucoma and retinal disorders (16 papers). Jingsheng Tuo is often cited by papers focused on Retinal Diseases and Treatments (60 papers), Retinal Development and Disorders (29 papers) and Glaucoma and retinal disorders (16 papers). Jingsheng Tuo collaborates with scholars based in United States, China and Poland. Jingsheng Tuo's co-authors include Chi‐Chao Chan, Defen Shen, Christine M. Bojanowski, Emily Y. Chew, Robert J. Ross, Vilhelm A. Bohr, Xiaoguang Cao, Henrik E. Poulsen, Steffen Loft and Paweł Jaruga and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Jingsheng Tuo

105 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingsheng Tuo United States 38 1.9k 1.8k 790 479 429 109 3.6k
Marta García‐Ramírez Spain 34 1.7k 0.9× 2.0k 1.1× 789 1.0× 216 0.5× 415 1.0× 66 3.8k
Debasish Sinha United States 32 1.3k 0.7× 1.6k 0.9× 462 0.6× 506 1.1× 306 0.7× 78 3.0k
Chiara Gerhardinger United States 28 1.2k 0.6× 1.9k 1.0× 466 0.6× 213 0.4× 378 0.9× 45 3.3k
Jianhai Du United States 36 1.0k 0.5× 2.4k 1.3× 282 0.4× 171 0.4× 203 0.5× 95 3.3k
Barbara Wiggert United States 29 937 0.5× 1.7k 0.9× 150 0.2× 607 1.3× 149 0.3× 78 2.9k
Peter D. Westenskow United States 24 896 0.5× 1.6k 0.9× 526 0.7× 174 0.4× 139 0.3× 53 2.5k
Jeremy M. Sivak Canada 20 620 0.3× 863 0.5× 515 0.7× 110 0.2× 179 0.4× 47 1.9k
David J. Figueroa United States 23 478 0.2× 2.0k 1.1× 159 0.2× 557 1.2× 70 0.2× 44 3.8k
Isabelle Petropoulos France 28 325 0.2× 1.8k 1.0× 185 0.2× 138 0.3× 66 0.2× 83 3.0k
Lin Jia China 24 366 0.2× 1.1k 0.6× 94 0.1× 417 0.9× 604 1.4× 77 2.2k

Countries citing papers authored by Jingsheng Tuo

Since Specialization
Citations

This map shows the geographic impact of Jingsheng Tuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingsheng Tuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingsheng Tuo more than expected).

Fields of papers citing papers by Jingsheng Tuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingsheng Tuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingsheng Tuo. The network helps show where Jingsheng Tuo may publish in the future.

Co-authorship network of co-authors of Jingsheng Tuo

This figure shows the co-authorship network connecting the top 25 collaborators of Jingsheng Tuo. A scholar is included among the top collaborators of Jingsheng Tuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingsheng Tuo. Jingsheng Tuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tuo, Jingsheng, Zhong Li, & Linshen Xie. (2025). Association between triglyceride-glucose index and clinical outcomes among patients with chronic kidney disease: a meta-analysis. BMC Nephrology. 26(1). 61–61. 3 indexed citations
4.
Chen, Shida, Defen Shen, Jingsheng Tuo, et al.. (2014). The involvement of IL-17RC pathway in the inflammatory stimuli of the multipotent retinal stem cells. Investigative Ophthalmology & Visual Science. 55(13). 3984–3984. 1 indexed citations
6.
Wang, Yujuan, Mones Abu‐Asab, Defen Shen, et al.. (2013). NLRP3 inflammasome activation in human retinal pigment epithelium under inflammation and oxidative stress. Investigative Ophthalmology & Visual Science. 54(15). 149–149. 2 indexed citations
7.
Chan, Chi‐Chao, Defen Shen, Yujuan Wang, et al.. (2013). Inflammasomes in human eyes with AMD and mouse retinas with focal retinal degeneration. Investigative Ophthalmology & Visual Science. 54(15). 315–315. 3 indexed citations
8.
Chu, Xi, Yujuan Wang, De Fen Shen, et al.. (2013). Adult human RPE has greater susceptibility to IL17A-induced degeneration than fetal human RPE. Investigative Ophthalmology & Visual Science. 54(15). 1780–1780. 1 indexed citations
9.
Liu, Melissa M., Chi‐Chao Chan, & Jingsheng Tuo. (2013). Epigenetics in Ocular Diseases. Current Genomics. 14(3). 166–172. 31 indexed citations
10.
Wang, Yujuan, Defen Shen, Jingsheng Tuo, et al.. (2012). Pigment Epithelium-derived Factor Inhibits Neuroretinal Apoptosis in a Murine Model of Focal Retinal Degeneration. Investigative Ophthalmology & Visual Science. 53(14). 4278–4278. 1 indexed citations
11.
Ardeljan, Daniel, Yujuan Wang, De Fen Shen, Jingsheng Tuo, & Chi‐Chao Chan. (2012). Treatment With Recombinant Interleukin-17A Reduces ARPE-19 Cell Viability. Investigative Ophthalmology & Visual Science. 53(14). 1227–1227. 2 indexed citations
12.
Ramkumar, Hema L., De Fen Shen, Jingsheng Tuo, et al.. (2012). IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas. Graefe s Archive for Clinical and Experimental Ophthalmology. 250(10). 1541–1548. 19 indexed citations
13.
Chan, Chi‐Chao, et al.. (2011). Expression Of IL-17 In Eyes Of Age-related Macular Degeneration. Investigative Ophthalmology & Visual Science. 52(14). 1228–1228. 2 indexed citations
14.
Tuo, Jingsheng, et al.. (2010). Synaptic Pathology of Photoreceptor Terminals in Ccl2/cx3cr1 Deficient Mice. Investigative Ophthalmology & Visual Science. 51(13). 4136–4136. 1 indexed citations
15.
Shen, De Fen, Jingsheng Tuo, Alexandra A. Herzlich, et al.. (2008). Chlamydia Pneumoniae Infection, Complement Factor H Variant, and Age-Related Macular Degeneration (AMD). Investigative Ophthalmology & Visual Science. 49(13). 1356–1356. 1 indexed citations
16.
Tuo, Jingsheng, Christine M. Bojanowski, Min Zhou, et al.. (2007). MurineCcl2/Cx3cr1Deficiency Results in Retinal Lesions Mimicking Human Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 48(8). 3827–3827. 173 indexed citations
17.
Wang, Jie Jin, Robert J. Ross, Jingsheng Tuo, et al.. (2007). The LOC387715 Polymorphism, Inflammatory Markers, Smoking, and Age-Related Macular Degeneration. Ophthalmology. 115(4). 693–699. 54 indexed citations
18.
Shen, De Fen, et al.. (2006). Hyporeactive Ocular Responses to Lipopolysaccharide in CCL2/CX3CR1 Double Deficient Mice. Investigative Ophthalmology & Visual Science. 47(13). 4521–4521. 1 indexed citations
19.
Chan, Chi‐Chao, Defen Shen, & Jingsheng Tuo. (2005). Polymerase Chain Reaction in the Diagnosis of Uveitis. International Ophthalmology Clinics. 45(2). 41–55. 15 indexed citations
20.
Müftüoğlu, Meltem, Rebecca R. Selzer, Jingsheng Tuo, Robert M. Brosh, & Vilhelm A. Bohr. (2002). Phenotypic consequences of mutations in the conserved motifs of the putative helicase domain of the human Cockayne Syndrome Group B gene. Gene. 283(1-2). 27–40. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026